Marksans Pharma stock has been one of the biggest shining light in my portfolio. I added this amazing stock from pharmaceuticals sector when it was available at Rs. 1.80 only. Yes, you heard it right! In fact, I had even discussed about this bullish pharma stock. In this article, we shall discuss about Marksans Pharma company background, current market price and expected levels in future.
BSE Id for Marksans Pharma – 524404
NSE Id for Marksans Pharma – MARKSANS
Current Marksans Pharma Share Price (as on 18th January’15) – INR 62.95
Arvind Bajaj’s Views About Marksans Pharma in his Portfolio
With the pharma sector gaining from its bullish nature, Marksans Pharma is proving to be one of the greatest jackpots. After adding this stock at a price of only Rs.1.80, I have seen it achieve recent high levels of Rs.72. Even though I and many of my friends have minted tonnes and tonnes in this bullish stock, I am holding it tight for higher levels of Rs.100 or Rs.120 and even more.
My Personal Bullish Expected Levels for Marksans Pharma – Rs.100 to 120 and beyond for long-term
Background for Marksans Pharma
It is a popular global pharmaceutical company. The headquarters for Marksans Pharma is in Mumbai. headquartered at Mumbai (India) is a global pharmaceutical company. They have been involved in Research&Development as well as offering CRAMS to pharma companies all over the world. Their major focus areas have always been prescription drugs and OTC with wide range of applications spread across various fields like Gynaecology, Oncology, Antibiotics, Gastroenterology, Anti-diabetic, Cardiovascular, Pain Management, etc.
You can access further information about this company at: Marksans Pharma Official Website
NOTE: The above information is purely my own personal take / view on Marksans Pharma based after my analysis. I am not at all a certified Stock Analyst or Stock Broker or Research Analyst. All my readers of this blog are advised to perform their own analysis and consult any authorized research analyst or financial advisor before taking their investment decision.